v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (35,059,852) $ (402,397)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation - Option grants 114,166
Advisory Shares committed for issuance 8,113,318  
Depreciation & Amortization expense 20,044
Change in fair value of derivative liability (48,279)
Interest expense 8,387 11,256
Accretion on Convertible notes 851,018 26,776
Unrealized gain from changes in fair value of digital assets 22,061,472
Non-cash digital asset operating expenses 8,726
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (273,390) 40
Accounts payable and accrued expenses 2,134,541 344,012
Operating lease liability 2,122
Net cash used in operating activities (2,067,727) (20,313)
Cash flows from investing activities:    
Redemption of short term investments 500,000
Purchases of PP&E (9,394)
Net cash provided by investing activities 490,606
Cash flows from financing activities:    
Proceeds from notes payable 995,000 250,000
Payment of issuance costs (75,000)
Cash advances from related parties 17,200
Net cash provided by financing activities 920,000 267,200
Net increase (decrease) in cash, cash equivalents and restricted cash (657,121) 246,887
Cash and cash equivalents, beginning of period 1,636,655 3,455
Restricted cash 8,000,000
Cash, cash equivalents, and restricted cash, end of period 8,979,534 250,432
Supplemental disclosure of cash flow information:    
Cash paid for interest
Cash paid for taxes
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 979,534 250,432
Restricted cash 8,000,000
Total cash, cash equivalents, and restricted cash $ 8,979,534 $ 250,432